Technical Analysis for SWTX - SpringWorks Therapeutics, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 33.63 | 1.60% | 0.53 |
SWTX closed down 1.25 percent on Tuesday, November 12, 2024, on 4.7 times normal volume. It was able to find support at its 50 day moving average. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Support | Bullish | 1.60% | |
50 DMA Support | Bullish | 1.60% | |
Volume Surge | Other | 1.60% | |
Wide Range Bar | Range Expansion | 1.60% | |
Upper Bollinger Band Walk | Strength | 1.60% | |
Earnings Movers | Other | 1.60% | |
Multiple of Ten Bullish | Other | 1.60% | |
Overbought Stochastic | Strength | 1.60% | |
Upper Bollinger Band Touch | Strength | 1.60% | |
Gapped Down | Weakness | 1.60% |
Alert | Time |
---|---|
Upper Bollinger Band Resistance | 34 minutes ago |
3x Volume Pace | about 1 hour ago |
2x Volume Pace | about 1 hour ago |
Gap Up Partially Closed | about 1 hour ago |
1.5x Volume Pace | about 1 hour ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/12/2024
Springworks Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It identifies pathways for drug development for patients with severe rare diseases and cancer. The firm's products include Nirogacestat, Mirdametinib and BGB-3245. The company was founded in August 2017 and is headquartered in Stamford, CT.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Pharmacy Rare Diseases Drug Development
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Pharmacy Rare Diseases Drug Development
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 53.92 |
52 Week Low | 19.61 |
Average Volume | 983,710 |
200-Day Moving Average | 40.30 |
50-Day Moving Average | 32.95 |
20-Day Moving Average | 30.98 |
10-Day Moving Average | 32.05 |
Average True Range | 1.70 |
RSI (14) | 58.16 |
ADX | 19.41 |
+DI | 24.72 |
-DI | 26.50 |
Chandelier Exit (Long, 3 ATRs) | 30.17 |
Chandelier Exit (Short, 3 ATRs) | 33.30 |
Upper Bollinger Bands | 34.02 |
Lower Bollinger Band | 27.94 |
Percent B (%b) | 0.85 |
BandWidth | 19.63 |
MACD Line | 0.24 |
MACD Signal Line | -0.33 |
MACD Histogram | 0.5687 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 40.99 | ||||
Resistance 3 (R3) | 40.68 | 37.73 | 39.68 | ||
Resistance 2 (R2) | 37.73 | 35.72 | 37.89 | 39.24 | |
Resistance 1 (R1) | 35.42 | 34.48 | 36.58 | 35.73 | 38.80 |
Pivot Point | 32.47 | 32.47 | 33.05 | 32.63 | 32.47 |
Support 1 (S1) | 30.16 | 30.46 | 31.32 | 30.47 | 27.40 |
Support 2 (S2) | 27.21 | 29.22 | 27.37 | 26.96 | |
Support 3 (S3) | 24.90 | 27.21 | 26.53 | ||
Support 4 (S4) | 25.21 |